Insider Trading & Ownership - Masson Kristina

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Masson Kristina

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-11-27
6:04 pm
N/A
2034-02-28
Acrivon Therapeutics Inc.ACRVBlume-Jensen Peter
Masson Kristina
President and CEO
315,316$0315,316
(Direct)
View
2024-11-21
Tax Withholding
2024-11-25
4:29 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVBlume-Jensen Peter
Masson Kristina
President and CEO
19,910$6.442,659,593
(Direct)
View
2024-11-14
Tax Withholding
2024-11-18
4:26 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVBlume-Jensen Peter
Masson Kristina
President and CEO
60,256$7.922,679,503
(Direct)
View
2024-08-21
Tax Withholding
2024-08-23
4:11 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVBlume-Jensen Peter
Masson Kristina
President and CEO
79,616$9.192,739,759
(Direct)
View
2024-08-14
Tax Withholding
2024-08-16
4:52 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMasson Kristina
EVP - Business Operations
490$7.022,819,375
(Direct)
View
2024-05-14
Tax Withholding
2024-05-16
7:02 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMasson Kristina
EVP - Business Operations
490$8.362,879,630
(Direct)
View
2024-02-14
Tax Withholding
2024-02-16
5:13 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMasson Kristina
EVP - Business Operations
579$3.42,935,038
(Direct)
View
2023-11-14
Tax Withholding
2023-11-16
7:42 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMasson Kristina
EVP - Business Operations
1,900$5.082,977,478
(Direct)
View
2022-11-14
Option Award
2022-11-16
7:10 pm
N/A
2032-11-13
Acrivon Therapeutics Inc.ACRVMasson Kristina
EVP - Business Operations
1,785,336$02,951,191
(Direct)
View

Ownership
2022-11-09
8:30 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMasson Kristina
EVP - Business Operations
0$01,601,465
(Direct)
View